Kurt Zatloukal - Selected Publications#


h=48 according to Google Hirsch Index (Jan. 2013)

Eder, J; Gottweis, H; Zatloukal, K;
IT Solutions for Privacy Protection in Biobanking. PUBLIC HEALTH GENOMICS. 2012; 15(5): 254-262.

Starmann, J; Fälth, M; Spindelböck, W; Lanz, KL; Lackner, C; Zatloukal, K; Trauner, M; Sültmann, H
Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis.
PLoS One. 2012; 7(10)
Viertler, C; Groelz, D; Gündisch, S; Kashofer, K; Reischauer, B; Riegman, PH; Winther, R; Wyrich, R; Becker, KF; Oelmüller, U; Zatloukal, K
A New Technology for Stabilization of Biomolecules in Tissues for Combined Histological and Molecular Analyses.
J Mol Diagn. 2012; 14(5):458-466

Zatloukal, K; Vaught, J
What Are the Next Steps to Overcoming Roadblocks to Transnational Biobank Collaboration?
BIOPRESERV BIOBANK. 2012; 10(1): 2-3.

Hallen, L; Klein, H; Stoschek, C; Wehrmeyer, S; Nonhoff, U; Ralser, M; Wilde, J; Röhr, C; Schweiger, MR; Zatloukal, K; Vingron, M; Lehrach, H; Konthur, Z; Krobitsch, S
The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2.
Hum Mol Genet. 2011; 20(1):104-114

Schröder, C; Heidtke, KR; Zacherl, N; Zatloukal, K; Taupitz, J
Safeguarding donors' personal rights and biobank autonomy in biobank networks: the CRIP privacy regime.
Cell Tissue Bank. 2011; 12(3):233-240

Bevilacqua, G; Bosman, F; Dassesse, T; Hofler, H; Janin, A; Langer, R; Larsimont, D; Morente, MM; Riegman, P; Schirmacher, P; Stanta, G; Zatloukal, K; Caboux, E; Hainaut, P
The role of the pathologist in tissue banking: European Consensus Expert Group Report.
Virchows Arch. 2010; 456(4):449-454

Hrzenjak, A; Moinfar, F; Kremser, ML; Strohmeier, B; Petru, E; Zatloukal, K; Denk, H
Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo.
Mol Cancer. 2010; 9(10):49-49

Zatloukal, K; Hainaut, P
Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicine.
 Biomark Med. 2010; 4(6):895-903

Imprint Privacy policy « This page (revision-2) was last updated on Wednesday, 27. November 2013, 15:07 by Kaiser Dana
  • operated by